Dr. Del Rosso discusses the current topical treatments available for patients with atopic dermatitis that have shown consistent efficacy with limited adverse events.
Dr. Dasilva discusses positive results from a recent study published in the Journal of Clinical and Aesthetic Dermatology that assessed the safety and efficacy of JAK inhibitors in a group of elderly patients. Click here to read the full article. Reference:
...
Lisa Swanson, MD, JCAD’s Section Editor of Pediatric Dermatology, shares her thoughts on new research evaluating maximum-use conditions for topical ruxolitinib cream in pediatric patients (2 to 11 years) with atopic dermatitis. Reference:
...
Dr. Cameron discusses promising results in a treatment that combined upadacitinib and topical corticosteroids. Reference:
...
Looking to the future of AD treatment, Dr. Song discusses the unmet need of predicting treatment responses in patients with atopic dermatitis, with the aim of avoiding the trial-and-error process of trying multiple medications.
...
Dr. Song discusses the latest safety data on topical and oral JAK inhibitors for patients with atopic dermatitis.
...
Melodie Young discusses managing treatment for younger children with atopic dermatitis, emphasizing the importance of focusing on potential and probable side effects with their caregivers.
...
